Activity value 75china Buyer&Supplier,Last transaction date:
2026-08-31
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for jiansu zhongbang pharmaceutical co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 67 transactions, with a transaction quantity of 7322 and a transaction weight of 40795.
5pharmevo pvt ltd.
pakistansupplier,they trade on 2026-04-20
194.75%
>
+View All
Products
Total 39
ProductsTransactionsPerDetail
telmisartan 3533.33%>
esomeprazole magnesium 2725.71%>
adc 2220.95%>
w mat 1817.14%>
pellets 1716.19%>
+View All
Hscode rank
Total 13
HSCode NameTransactionsPerDetail
HS 293339003836.19%>
HS 293399902725.71%>
HS 293499902523.81%>
HS 2933990098.57%>
HS 2933399032.86%>
+View All
Trading Area
Total 7
AreaTransactionsPerDetail
bangladesh17142.75%>
pakistan16942.25%>
vietnam102.50%>
united states41.00%>
peru30.75%>
+View All
Port statistics
Total 16
Port NameTransactionsPerDetail
bkk133.25%>
shanghai71.75%>
hangzhou41.00%>
riyadh41.00%>
hong kong30.75%>
+View All
jiansu zhongbang pharmaceutical co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as telmisartan,esomeprazole magnesium,adc.
According to the 52wmb.com global trade database, as of 2026-08-31, the company has completed 400 international trades,
with its main trading regions covering bangladesh,pakistan,vietnam etc.
The core products include HS29333900,HS29339990,HS29349990 etc,
often transported via bkk,port shanghai, port hangzhou etc,
and its main trading partners are eskayef pharmaceuticals ltd.,ccl pharmacetical pvt ltd.,hilton pharmp pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on jiansu zhongbang pharmaceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.